With the expanded indication, Efmody is now indicated for both adrenal insufficiency and congenital adrenal hyperplasia in patients aged 12 years or older.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/expanded-eu-indication-modified-release-cortisol-therapy-2026a100039b?src=rss
Author :
Publish date : 2026-02-02 15:53:00
Copyright for syndicated content belongs to the linked Source.